CNR2 and postmenopausal osteoporosis: Activation of CB2 promoted osteoblast cell survival and favored bone formation34–36 while inhibiting osteoclast differentiation and function—especially in postmenopausal osteoporosis, thus correlating with positive effect of estrogen on CB2 expression in both human and animal model37.